Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-15

FDA Approved: LACOSAMIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lacosamide from Sun Pharmaceutical Industries, Inc. to modify the approved generic lacosamide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

SUPPL AP for LACOSAMIDE (LACOSAMIDE)